Inhibition of guanylate cyclases by methylxanthines and papaverine.
The inhibition of guanylate cyclase activity by theophylline, methylisobutylxanthine, and papaverine has been studied with partially purified soluble and particulate enzyme preparations from rat organs. An excess of unlabeled cGMP has been used in the assays to eliminate significant further metabolism of the radioactive cGMP formed from [alpha-32P]GTP. All of the guanylate cyclases examined were significantly inhibited by millimolar concentrations of theophylline and papaverine. Inhibition of soluble liver guanylate cyclase by theophylline was competitive with respect to GTP while inhibition by papaverine was noncompetitive. Thus, some drugs which are often used as inhibitors of cyclic nucleotide phosphodiesterases can inhibit guanylate cyclases as well.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000201:enzymology*; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors*; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008168:Lung / Q000201:enzymology*; D008297:Male; D009928:Organ Specificity; D010208:Papaverine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology*
D013806:Theophylline; D010208:Papaverine; D006162:Guanylate Cyclase; D015056:1-Methyl-3-isobutylxanthine